We found that ROCK2-knockdown increased the sensitivity of CCA cells to Pemigatinib, while the addition of DFO blocked this process, and there is no significant difference in the total weights of the mice (Fig. 3I–L and S6A, B). Here, ROCK2 is linked to cholangiocarcinoma.